Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
06/2005
06/15/2005EP1539736A1 Substituted 1,4-pyrazine derivatives
06/15/2005EP1539735A1 Piperazine urea derivatives as melanocortin-4 receptor agonists
06/15/2005EP1539734A1 Piperidine quinolyl propyl derivatives and use thereof as antimicrobial agents
06/15/2005EP1539733A2 Azabicyclic compounds are central nervous system active agents
06/15/2005EP1539718A1 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same
06/15/2005EP1539717A2 Microbiocidal (e.g fungicidal) 1,2,3-triazole derivatives
06/15/2005EP1539716A1 Benzodiazepine derivatives and pharmaceutical compositions containing them
06/15/2005EP1539713A1 Pyrimidine derivatives as modulators of chemokine receptor activity
06/15/2005EP1539712A1 Pyrimidine derivatives and their use as cb2 modulators
06/15/2005EP1539710A1 Heterocyclic derivatives
06/15/2005EP1539708A1 Benzimidazolones and their use as cytokine inhibitors
06/15/2005EP1539706A1 1-sulphonyl piperidine derivatives
06/15/2005EP1539705A2 Novel benzohydrazide derivatives as herbicides and desiccant compositions contaning them
06/15/2005EP1539702A2 Hydrophilic chemiluminescent acridinium labeling reagents
06/15/2005EP1539700A1 8-hydroxy quinoline derivatives
06/15/2005EP1539697A1 Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs
06/15/2005EP1539696A2 Process for preparing quinolin antibiotic intermediates
06/15/2005EP1539693A1 Cannabinoid receptor agonists
06/15/2005EP1539180A2 Compounds, compositions, and methods
06/15/2005EP1539178A2 Protease inhibitors
06/15/2005EP1539163A1 4-hydroxyquinoline derivatives as matrix metalloproteinase inhibitors
06/15/2005EP1539161A1 Novel salt and polymorphs of desloratadine hemifumarate
06/15/2005EP1539159A1 Sulphonylpiperidine derivatives containing an aryl or heteroaryl group for use as matrix metalloproteinase inhibitors
06/15/2005EP1539158A1 Aryl piperidine derivatives as inducers of ldl-receptor expression for the treatment of hypercholesterolemia
06/15/2005EP1539156A1 Liquid dosage forms of acid labile drugs
06/15/2005EP1539151A1 Biaryl compounds having anti-infective activity
06/15/2005EP1539150A1 Naphthalimide synthesis including amonafide synthesis and pharmaceutical preparations thereof
06/15/2005EP1539141A1 -3 (sulfonamidoethyl) -indole derivaties for use as glucocorticoid mimetics in the treatment of inflammatory, allergic and proliferative diseases
06/15/2005EP1450808B1 Quinazoline derivatives for the treatment of t cell mediated diseases
06/15/2005EP1368337B1 Piperazine derivatives and their use as 5-ht1b ligands
06/15/2005EP1349856B1 Isoindolin-1-one glucokinase activators
06/15/2005EP1341764B1 Ortho-substituted nitrogen-containing bisaryl compounds used as potassium channel inhibitors
06/15/2005EP1311504B1 Tetrazolyl-phenyl acetamide glucokinase activators
06/15/2005EP1278740B1 Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
06/15/2005EP1256576B1 Fused imidazolium derivatives
06/15/2005EP1150973B1 Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents
06/15/2005EP1134219B1 Cycloalkyl-substituted aminomethylpyrrolidine derivatives
06/15/2005EP1064277B1 2-(2,6-dioxopiperidin-3-yl)isoindoline derivatives, their preparation and their use as inhibitors of inflammatory cytokines
06/15/2005EP0991654B1 Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and compositions containing same
06/15/2005EP0975602B1 Imidazole and imidazoline derivatives and uses thereof
06/15/2005EP0923555B1 Carboxamide derivatives of pyrrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorders
06/15/2005CN1628112A Polymorph of acid 4-[2-[4-[1-2-ethoxyethyl)-1h-benzimidazole-2-il]-1-piper idinyl]ethyl]-dollar G (A), dollar G (A)-dimethyl-benzeneacetic
06/15/2005CN1628109A Novel aryl- and heteroarylpiperazines
06/15/2005CN1628103A Pyrimidine derivitive
06/15/2005CN1628100A Gamma secretase inhibitors
06/15/2005CN1627945A Quinoline derivatives as NPY antagonists
06/15/2005CN1627944A Substituted quinazolin-4-ylamine analogues as modulators of capsaicin
06/15/2005CN1626534A Steroid receptor modulator compounds and methods
06/15/2005CN1626516A Novel intermediate for prepn. of pyrazolopyrimidinones
06/15/2005CN1206228C N-heterocyclic derivatives as NOS inhibitors
06/15/2005CN1206219C N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
06/14/2005US6906632 Vehicular sound-processing system incorporating an interior mirror user-interaction site for a restricted-range wireless communication system
06/14/2005US6906192 Processes for the preparation of acid derivatives useful as serine protease inhibitors
06/14/2005US6906103 Compounds possessing antibacterial, antifungal or antitumor activity
06/14/2005US6906095 Central nervous system disorders; anxiolytic agents; antidepressants; muscular disorders
06/14/2005US6906093 Indolinone combinatorial libraries and related products and methods for the treatment of disease
06/14/2005US6906090 Compositions and methods for treating mycobacterial diseases
06/14/2005US6906089 Kidney disease; cardiovascular disorders; antiscarring agents; wound healing agents
06/14/2005US6906084 Indole derivatives as factor Xa inhibitors
06/14/2005US6906080 Antiinflammatory agents, analgesics, drug abuse, alcoholism
06/14/2005US6906078 Method of using (H+/K+) ATPase inhibitors as antiviral agents
06/14/2005US6906075 Contacting a sample with substituted benzoimidazole analogues under conditions that permit binding of such analogue to melanin concentrating hormone (MCH) receptor to determine the presence and absence of MCH
06/14/2005US6906074 A tachykinin antagonist for used as antiinflammatory agent, antiallergic agent, analgesic, antiemetics, treating irritable colon syndrome, skin disorders
06/14/2005US6906072 Central nervous system disorders
06/14/2005US6906070 Anticoagulants
06/14/2005US6906068 Substituted polycyclic aryl and heteroaryl 1,2,4 - triazinones useful as anticoagulants
06/14/2005US6906067 Block cytokine production via inhibition of p38 kinase; triamino-s-triazine compounds; treating rheumatoid arthritis
06/14/2005US6906066 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
06/14/2005US6906065 4-Amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases
06/14/2005US6906063 For therapy and prophylaxis of thrombosis in a mammal
06/14/2005US6906056 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
06/14/2005US6906053 Antiarthritic agents; antiulcer agents; osteoporosis; antiinflammatory agents; antitumor and anticancer agents
06/14/2005US6906006 Applying to plants, environment
06/14/2005US6905455 Radioactive member and method of making
06/14/2005CA2304967C 4(3)substituted-4(3)-aminomethyl-(thio)pyran or -piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
06/14/2005CA2234096C 1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives
06/14/2005CA2155952C Novel process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis
06/09/2005WO2005051945A1 Heterocyclic compounds as modulators of peroxisome proliferator activated receptors, useful for the treatment and/or prevention of disorders modulated by a ppar
06/09/2005WO2005051942A1 Indazole compounds and methods of use thereof as protein kinase inhibitors
06/09/2005WO2005051923A1 Quinazoline derivatives
06/09/2005WO2005051922A1 Quinazolinone compounds as anticancer agents
06/09/2005WO2005051919A1 Aminopyrazole derivatives as gsk-3 inhibitors
06/09/2005WO2005051918A1 Cationic diaminopyrazoles, a method for the production thereof and dyes containing these compounds
06/09/2005WO2005051917A1 Pyrazolyl derivatives in the form of drugs for treating acute or chronic neuronal regressions
06/09/2005WO2005051914A1 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
06/09/2005WO2005051913A1 Cyclic amine derivative having heteroaryl ring
06/09/2005WO2005051911A1 4-phenylpiperidine derivatives as renin inhibitors
06/09/2005WO2005051906A2 Heterocyclic inhibitors of mek and methods of use thereof
06/09/2005WO2005051901A1 Anti-cancer agents
06/09/2005WO2005051391A1 Quinazolinone compounds with reduced bioaccumulation
06/09/2005WO2005051390A1 E-fluoro-4-(pyridin-2-yl)-piperidine-1-carboxamide derivatives and related compounds which modulate the function of the vanilloid-1 receptor (vr1) for the treatment of pain
06/09/2005WO2005051387A1 Amino substituted pyridinyl methanone compounds useful in treating kinase disorders
06/09/2005WO2005051386A1 Hmg-coa reductase inhibitors and method
06/09/2005WO2005051381A1 Substituted urea-octatydroindols as antagonists of melanin concentrating hormone receptor 1 (MCH1R)
06/09/2005WO2005051380A1 Substituted urea-octahydroindols as antagonists of melanin concentrating hormone receptor 1 (mch1r)
06/09/2005WO2005051367A1 Carboxamide and amino derivatives and methods of their use
06/09/2005WO2005051366A2 Diaryl urea derivatives in the treatment of protein kinase dependent diseases
06/09/2005WO2005051308A2 Methods of treating diseases and disorders by targeting multiple kinases
06/09/2005WO2005051302A2 Bicyclic inhibitors of mek and methods of use thereof
06/09/2005WO2005051301A2 Heterocyclic inhibitors of mek and methods of use thereof
1 ... 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 ... 1080